Device
PENS
PENS is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
80%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (20.0%)
N/A4 (80.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Neuromodulation in Professional Dancers
NCT03596216
completednot_applicable
PENS or TENS for Pain in Pancreatic Cancer
NCT03331055
completednot_applicable
PENS or TENS for Pain in Liver Cancer
NCT03338543
completednot_applicable
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
NCT02441712
completedphase_3
Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis
NCT02434419
Clinical Trials (5)
Showing 5 of 5 trials
NCT03596216Not Applicable
Neuromodulation in Professional Dancers
NCT03331055Not Applicable
PENS or TENS for Pain in Pancreatic Cancer
NCT03338543Not Applicable
PENS or TENS for Pain in Liver Cancer
NCT02441712Not Applicable
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
NCT02434419Phase 3
Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5